antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.

MLA

Weidong Zhang, et al. “Antigen Sm-P80: Prophylactic Efficacy Using TLR4 Agonist Vaccine Adjuvant Glucopyranosyl Lipid A-Alum in Murine and Non-Human Primate Models.” Journal of Investigative Medicine (Sage Publications Inc.), vol. 66, no. 8, Dec. 2018, pp. 1124–32. EBSCOhost, https://doi.org/10.1136/jim-2018-000786.

APA

Weidong Zhang, Ahmad, G., Molehin, A. J., Torben, W., Loc Le, Eunjee Kim, Lazarus, S., Siddiqui, A. J., Carter, D., Siddiqui, A. A., Zhang, W., Le, L., & Kim, E. (2018). antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models. Journal of Investigative Medicine (Sage Publications Inc.), 66(8), 1124–1132. https://doi.org/10.1136/jim-2018-000786

Chicago

Weidong Zhang, Gul Ahmad, Adebayo J. Molehin, Workineh Torben, Loc Le, Eunjee Kim, Samra Lazarus, et al. 2018. “Antigen Sm-P80: Prophylactic Efficacy Using TLR4 Agonist Vaccine Adjuvant Glucopyranosyl Lipid A-Alum in Murine and Non-Human Primate Models.” Journal of Investigative Medicine (Sage Publications Inc.) 66 (8): 1124–32. doi:10.1136/jim-2018-000786.